IKENA ONCOLOGY INC (IKNA) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:IKNA • US45175G1085

1.43 USD
+0.06 (+4.38%)
At close: Jul 25, 2025
1.46 USD
+0.03 (+2.1%)
After Hours: 7/25/2025, 8:00:01 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to IKNA. IKNA was compared to 190 industry peers in the Pharmaceuticals industry. IKNA has a great financial health rating, but its profitability evaluates not so good. IKNA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • IKNA had negative earnings in the past year.
  • IKNA had a negative operating cash flow in the past year.
  • IKNA had negative earnings in each of the past 5 years.
  • In the past 5 years IKNA always reported negative operating cash flow.
IKNA Yearly Net Income VS EBIT VS OCF VS FCFIKNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M -80M

1.2 Ratios

  • The Return On Assets of IKNA (-34.79%) is comparable to the rest of the industry.
  • IKNA's Return On Equity of -39.10% is in line compared to the rest of the industry. IKNA outperforms 56.19% of its industry peers.
Industry RankSector Rank
ROA -34.79%
ROE -39.1%
ROIC N/A
ROA(3y)-36.73%
ROA(5y)-30.05%
ROE(3y)-42.01%
ROE(5y)-36.93%
ROIC(3y)N/A
ROIC(5y)N/A
IKNA Yearly ROA, ROE, ROICIKNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for IKNA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IKNA Yearly Profit, Operating, Gross MarginsIKNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 -1K -2K -3K -4K

More info and screens

7

2. Health

2.1 Basic Checks

  • IKNA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, IKNA has about the same amount of shares outstanding.
  • Compared to 5 years ago, IKNA has more shares outstanding
  • IKNA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IKNA Yearly Shares OutstandingIKNA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
IKNA Yearly Total Debt VS Total AssetsIKNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • IKNA has an Altman-Z score of -2.95. This is a bad value and indicates that IKNA is not financially healthy and even has some risk of bankruptcy.
  • IKNA has a Altman-Z score of -2.95. This is comparable to the rest of the industry: IKNA outperforms 44.33% of its industry peers.
  • IKNA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.95
ROIC/WACCN/A
WACC9.74%
IKNA Yearly LT Debt VS Equity VS FCFIKNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M 200M

2.3 Liquidity

  • IKNA has a Current Ratio of 11.80. This indicates that IKNA is financially healthy and has no problem in meeting its short term obligations.
  • IKNA's Current ratio of 11.80 is amongst the best of the industry. IKNA outperforms 85.05% of its industry peers.
  • A Quick Ratio of 11.80 indicates that IKNA has no problem at all paying its short term obligations.
  • The Quick ratio of IKNA (11.80) is better than 85.05% of its industry peers.
Industry RankSector Rank
Current Ratio 11.8
Quick Ratio 11.8
IKNA Yearly Current Assets VS Current LiabilitesIKNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

1

3. Growth

3.1 Past

  • The earnings per share for IKNA have decreased strongly by -121.62% in the last year.
  • IKNA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -100.00%.
EPS 1Y (TTM)-121.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-157.14%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • IKNA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.75% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y41.43%
EPS Next 2Y17.21%
EPS Next 3Y7.65%
EPS Next 5Y14.75%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IKNA Yearly Revenue VS EstimatesIKNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2029 2030 2031 2032 50M 100M
IKNA Yearly EPS VS EstimatesIKNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -1 -2 -3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • IKNA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year IKNA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IKNA Price Earnings VS Forward Price EarningsIKNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IKNA Per share dataIKNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.21%
EPS Next 3Y7.65%

More info and screens

0

5. Dividend

5.1 Amount

  • IKNA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IKENA ONCOLOGY INC / IKNA FAQ

What is the ChartMill fundamental rating of IKENA ONCOLOGY INC (IKNA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to IKNA.


Can you provide the valuation status for IKENA ONCOLOGY INC?

ChartMill assigns a valuation rating of 0 / 10 to IKENA ONCOLOGY INC (IKNA). This can be considered as Overvalued.


Can you provide the profitability details for IKENA ONCOLOGY INC?

IKENA ONCOLOGY INC (IKNA) has a profitability rating of 1 / 10.


What is the financial health of IKENA ONCOLOGY INC (IKNA) stock?

The financial health rating of IKENA ONCOLOGY INC (IKNA) is 7 / 10.